Dr Schulz studied medicine in Aachen (Germany), and came to the UK in 1996. She completed her general medical training in Glasgow before coming to Oxford to do a D.Phil. in the Stroke Prevention Research Unit as a Wellcome Clinical Research Fellow. She returned to Scotland to complete her Neurology training and then came back to Oxford after having been awarded an NIHR Clinician Scientist Award.
Awards Training and Qualifications
- 2008- 2013 NIHR Clinician Scientist Fellowship, NIHR
- 2008 CCST in Neurology, JCHMT (UK)
- 2001- 2004 Wellcome Trust Clinical Research Fellowship, Wellcome Trust
- 1998 MRCP (UK), Royal College of Physicians
- 1995 Dr.med (German Postgraduate Medical Degree), RWTH Aachen
- 1994 German Medical State Examination, Deutsche Arztekammer
D.Phil MRCP (UK)
NIHR Clinician Scientist
- Stroke Prevention Research Unit
Dr Schulz is a NIHR Clinician Scientist at the Stroke Prevention Research Unit and an Honorary Consultant Neurologist within the University Department of Clinical Neurosciences (Neurology Division). She is based in the newly opened Acute Vascular Imaging Centre (AVIC). Her main research interest is MR-imaging after TIA and minor stroke. She studies the clinical usefulness of established MRI-techniques and also explores possible clinical applications for newly developed MR-sequences in close collaboration with the centre for functional MRI of the brain (FMRIB). Dr Schulz is particularly interested in patients with posterior circulation disease, their prognosis and risk factors. In addition to conducting clinical and imaging studies, she is also the main investigator for the Vertebral Artery Ischaemia Stenting Trial (VIST) in Oxford. This multi-centre trial compares best medical treatment versus best medical treatment plus intervention (stenting or angioplasty) in patients with a recently symptomatic vertebral artery stenosis.
Sources of Funding
Vertebral artery stenting to prevent recurrent stroke in symptomatic vertebral artery stenosis: the VIST RCT.
Markus HS. et al, (2019), Health technology assessment (Winchester, England), 23, 1 - 30
Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis.
Markus HS. et al, (2019), Lancet Neurol, 18, 666 - 673
Endovascular treatment of patients with high-risk symptomatic intracranial vertebrobasilar stenoses: Long - Term outcomes
Djurdjevic T. et al, (2019), Stroke and Vascular Neurology
Cryptogenic stroke - How to make sense of a non-diagnostic entity.
Schulz UG., (2019), Maturitas, 122, 44 - 50
Stenting for Symptomatic Vertebral Artery Stenosis: The Vertebral Artery Ischaemia Stenting Trial
Markus HS. et al, (2018), Journal of Vascular Surgery, 67, 986 - 986